Search

Search Results

• Finerenone as a therapeutic option for managing chronic kidney disease (CKD) linked to type 2 diabetes (T2D) and his other potential use. A summary of current research findings

  Cezary Kubuj, Grzegorz Adaśko, Michał Świda, Jakub Bazarewicz, Urszula Mazur, Marcin Siwik, Daniel Dmowski, Anna Michalska, Paulina Ogonowska, Julia Waszak

  62411

  2025-07-11
• Nephrological complications in patients after COVID-19 infection

  Agnieszka Marciniak, Sylwia Nemeczek, Klaudia Walczak, Patrycja Walczak, Konrad Merkisz, Jakub Grzybowski, Natalia Grzywna, Karolina Jaskuła, Władysław Orłowski

  29-34

  2023-01-17
• Current Approaches to Treatment and Protein Intake Management in Pre-Dialysis Chronic Kidney Disease: Impact on Physical Exercise

  Olga Beata Wieczorek, Daria Aleksandrowicz, Marta Głąbień, Zofia Jakubczak, Paweł Miłkowski, Maria Weronika Zimniak, Aneta Kondratowicz, Patryk Śliwiak, Karolina Kusiak, Anna Kuśnierz

  54956

  2024-10-18
• The Application of Incretin-Based Pharmacotherapy in the Contemporary Management of Type 2 Diabetes: A Review of the Literature

  Jakub Waszczyński, Wojciech Kulej, Wiktor Biesiada, Piotr Kulej, Justyna Woźniak, Justyna Weronika Kmieć, Anna Mariia Chernysh, Aleksandra Dusińska, Kamila Fuczyło, Karolina Stankević

  57253

  2025-01-22
• Sodium–glucose co-transporter-2 inhibitors - empagliflozin and dapagliflozin as future therapy for Alport Syndrome, literature review

  Magdalena Kłusek, Katarzyna Chawrylak, Julia Kuszneruk, Maria Kubas, Katarzyna Krzemińska

  53252

  2024-07-25